{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:14:53Z","timestamp":1789496093922,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:00:00Z","timestamp":1652140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:00:00Z","timestamp":1652140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The etiopathogenesis of coronavirus disease 2019 (COVID-19) stem partially from the abnormal activation of the innate and adaptive immune systems. Here in the current investigation, the mRNA expression levels of toll-like receptors (TLRs) were evaluated in the nasopharyngeal epithelial cells from COVID-19 patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Epithelial cells were obtained using nasopharyngeal swab samples from 90 COVID-19 patients and 50 controls. COVID-19 cases were classified into those without symptoms, with symptoms but not hospitalized, and with symptoms and hospitalized. To determine the mRNA expression levels of TLRs, first RNA was extracted and cDNA was synthesized, and finally Real-time PCR was exerted.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>It was seen that the transcript levels of TLR3, TLR7, TLR8, and TLR9 were overexpressed in the COVID-19 patients with clinical symptoms needing hospitalization as well as in those with clinical symptoms without needing for hospitalization compared to controls. Upregulation of TLRs was associated with clinical presentations of the patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Modulation of TLR3, TLR7, TLR8, TLR9 in the epithelial cells of COVID-19 cases may estimate the disease severity and requirement for hospitalization.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-022-07437-9","type":"journal-article","created":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T09:04:44Z","timestamp":1652173484000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["mRNA expression of toll-like receptors 3, 7, 8, and 9 in the nasopharyngeal epithelial cells of coronavirus disease 2019 patients"],"prefix":"10.1186","volume":"22","author":[{"given":"Zahra","family":"Bagheri-Hosseinabadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebrahim","family":"Rezazadeh Zarandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Mirabzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Amiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitra","family":"Abbasifard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,10]]},"reference":[{"issue":"3","key":"7437_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105924","volume":"55","author":"CC Lai","year":"2020","unstructured":"Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020;55(3): 105924.","journal-title":"Int J Antimicrob Agents"},{"issue":"21","key":"7437_CR2","doi-asserted-by":"publisher","first-page":"11727","DOI":"10.1073\/pnas.2003138117","volume":"117","author":"J Shang","year":"2020","unstructured":"Shang J, Wan Y, Luo C, Ye G, Geng Q, Auerbach A, Li F. Cell entry mechanisms of SARS-CoV-2. Proc Natl Acad Sci. 2020;117(21):11727\u201334.","journal-title":"Proc Natl Acad Sci"},{"key":"7437_CR3","unstructured":"Organization WH: Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance, 13 March 2020. In.: World Health Organization; 2020."},{"key":"7437_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108076","volume":"100","author":"M Mohammadhosayni","year":"2021","unstructured":"Mohammadhosayni M, Mohammadi FS, Ezzatifar F, Gorabi AM, Khosrojerdi A, Aslani S, Hemmatzadeh M, Yazdani S, Arabi M, Marofi F. Matrix metalloproteinases are involved in the development of neurological complications in patients with Coronavirus disease 2019. Int Immunopharmacol. 2021;100: 108076.","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"7437_CR5","doi-asserted-by":"publisher","first-page":"855","DOI":"10.4049\/jimmunol.1402513","volume":"194","author":"S Han","year":"2015","unstructured":"Han S, Mallampalli RK. The acute respiratory distress syndrome: from mechanism to translation. J Immunol. 2015;194(3):855\u201360.","journal-title":"J Immunol"},{"key":"7437_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118097","volume":"257","author":"M Abbasifard","year":"2020","unstructured":"Abbasifard M, Khorramdelazad H. The bio-mission of interleukin-6 in the pathogenesis of COVID-19: a brief look at potential therapeutic tactics. Life Sci. 2020;257: 118097.","journal-title":"Life Sci"},{"issue":"1","key":"7437_CR7","first-page":"65","volume":"18","author":"Z Bagheri-Hosseinabadi","year":"2021","unstructured":"Bagheri-Hosseinabadi Z, Ostad Ebrahimi H, Bahrehmand F, Taghipour G, Abbasifard M. The relationship between serum levels of interleukin-2 and IL-8 with circulating microRNA-10b in patients with COVID-19. Iran J Immunol: IJI. 2021;18(1):65\u201373.","journal-title":"Iran J Immunol: IJI"},{"key":"7437_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107082","volume":"89","author":"N Ebrahimi","year":"2020","unstructured":"Ebrahimi N, Aslani S, Babaie F, Hemmatzadeh M, Hosseinzadeh R, Joneidi Z, Tourzani ZM, Pakravan N, Mohammadi H. Recent findings on the Coronavirus disease 2019 (COVID-19); immunopathogenesis and immunotherapeutics. Int Immunopharmacol. 2020;89: 107082.","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"7437_CR9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s12026-020-09137-5","volume":"68","author":"D Birra","year":"2020","unstructured":"Birra D, Benucci M, Landolfi L, Merchionda A, Loi G, Amato P, Licata G, Quartuccio L, Triggiani M, Moscato P. COVID 19: a clue from innate immunity. Immunol Res. 2020;68(3):161\u20138.","journal-title":"Immunol Res"},{"issue":"9","key":"7437_CR10","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S1473-3099(11)70099-8","volume":"11","author":"M Hedayat","year":"2011","unstructured":"Hedayat M, Netea MG, Rezaei N. Targeting of Toll-like receptors: a decade of progress in combating infectious diseases. Lancet Infect Dis. 2011;11(9):702\u201312.","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"7437_CR11","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.jmb.2013.11.024","volume":"426","author":"SN Lester","year":"2014","unstructured":"Lester SN, Li K. Toll-like receptors in antiviral innate immunity. J Mol Biol. 2014;426(6):1246\u201364.","journal-title":"J Mol Biol"},{"key":"7437_CR12","doi-asserted-by":"publisher","first-page":"9914854","DOI":"10.1155\/2021\/9914854","volume":"2021","author":"P Behzadi","year":"2021","unstructured":"Behzadi P, Garc\u00eda-Perdomo HA, Karpi\u0144ski TM. Toll-like receptors: general molecular and structural biology. J Immunol Res. 2021;2021:9914854.","journal-title":"J Immunol Res"},{"issue":"7","key":"7437_CR13","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nri1391","volume":"4","author":"S Akira","year":"2004","unstructured":"Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol. 2004;4(7):499\u2013511.","journal-title":"Nat Rev Immunol"},{"key":"7437_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103500","volume":"70","author":"H Chen","year":"2021","unstructured":"Chen H, Liu W, Wang Y, Liu D, Zhao L, Yu J. SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients. EBioMedicine. 2021;70: 103500.","journal-title":"EBioMedicine"},{"issue":"6","key":"7437_CR15","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.coviro.2011.10.006","volume":"1","author":"N Arpaia","year":"2011","unstructured":"Arpaia N, Barton GM. Toll-like receptors: key players in antiviral immunity. Curr Opin Virol. 2011;1(6):447\u201354.","journal-title":"Curr Opin Virol"},{"key":"7437_CR16","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.3389\/fimmu.2020.583373","volume":"11","author":"JC de Rivero Vaccari","year":"2020","unstructured":"de Rivero Vaccari JC, Dietrich WD, Keane RW, de Rivero Vaccari JP. The inflammasome in times of COVID-19. Front Immunol. 2020;11:2474.","journal-title":"Front Immunol"},{"issue":"3","key":"7437_CR17","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1365-2249.2010.04196.x","volume":"161","author":"M Carty","year":"2010","unstructured":"Carty M, Bowie AG. Recent insights into the role of Toll-like receptors in viral infection. Clin Exp Immunol. 2010;161(3):397\u2013406.","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"7437_CR18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1684\/ecn.2020.0448","volume":"31","author":"H Mojtabavi","year":"2020","unstructured":"Mojtabavi H, Saghazadeh A, Rezaei N. Interleukin-6 and severe COVID-19: a systematic review and meta-analysis. Eur Cytokine Netw. 2020;31(2):44\u20139.","journal-title":"Eur Cytokine Netw"},{"issue":"10","key":"7437_CR19","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1002\/jmv.26123","volume":"92","author":"M Lotfi","year":"2020","unstructured":"Lotfi M, Rezaei N. SARS-CoV-2: a comprehensive review from pathogenicity of the virus to clinical consequences. J Med Virol. 2020;92(10):1864\u201374.","journal-title":"J Med Virol"},{"key":"7437_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2020.108961","volume":"126","author":"C Long","year":"2020","unstructured":"Long C, Xu H, Shen Q, Zhang X, Fan B, Wang C, Zeng B, Li Z, Li X, Li H. Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT? Eur J Radiol. 2020;126: 108961.","journal-title":"Eur J Radiol"},{"issue":"4","key":"7437_CR21","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.anorl.2020.06.001","volume":"137","author":"S Pondaven-Letourmy","year":"2020","unstructured":"Pondaven-Letourmy S, Alvin F, Boumghit Y, Simon F. How to perform a nasopharyngeal swab in adults and children in the COVID-19 era. Eur Ann Otorhinolaryngol Head Neck Dis. 2020;137(4):325\u20137.","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"issue":"4","key":"7437_CR22","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s42977-021-00095-z","volume":"72","author":"P Behzadi","year":"2021","unstructured":"Behzadi P, Gajd\u00e1cs M. Writing a strong scientific paper in medicine and the biomedical sciences: a checklist and recommendations for early career researchers. Biologia futura. 2021;72(4):395\u2013407.","journal-title":"Biologia futura"},{"issue":"6","key":"7437_CR23","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative CT method. Nat Protoc. 2008;3(6):1101\u20138.","journal-title":"Nat Protoc"},{"issue":"3","key":"7437_CR24","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s00011-022-01545-7","volume":"71","author":"Z Bagheri-Hosseinabadi","year":"2022","unstructured":"Bagheri-Hosseinabadi Z, Abbasi M, Kahnooji M, Ghorbani Z, Abbasifard M. The prognostic value of S100A calcium binding protein family members in predicting severe forms of COVID-19. Inflamm Res. 2022;71(3):369\u201376.","journal-title":"Inflamm Res"},{"key":"7437_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117900","volume":"256","author":"F Yazdanpanah","year":"2020","unstructured":"Yazdanpanah F, Hamblin MR, Rezaei N. The immune system and COVID-19: friend or foe? Life Sci. 2020;256: 117900.","journal-title":"Life Sci"},{"issue":"7","key":"7437_CR26","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1001\/jama.2020.13719","volume":"324","author":"CI Van Der Made","year":"2020","unstructured":"Van Der Made CI, Simons A, Schuurs-Hoeijmakers J, Van Den Heuvel G, Mantere T, Kersten S, Van Deuren RC, Steehouwer M, Van Reijmersdal SV, Jaeger M. Presence of genetic variants among young men with severe COVID-19. JAMA. 2020;324(7):663\u201373.","journal-title":"JAMA"},{"issue":"4\u20135","key":"7437_CR27","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.micinf.2020.04.009","volume":"22","author":"MA Moreno-Eutimio","year":"2020","unstructured":"Moreno-Eutimio MA, L\u00f3pez-Mac\u00edas C, Pastelin-Palacios R. Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7\/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes. Microbes Infect. 2020;22(4\u20135):226\u20139.","journal-title":"Microbes Infect"},{"issue":"12","key":"7437_CR28","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201129","volume":"217","author":"FP Veras","year":"2020","unstructured":"Veras FP, Pontelli MC, Silva CM, Toller-Kawahisa JE, de Lima M, Nascimento DC, Schneider AH, Caetit\u00e9 D, Tavares LA, Paiva IM. SARS-CoV-2\u2013triggered neutrophil extracellular traps mediate COVID-19 pathology. J Exp Med. 2020;217(12): e20201129.","journal-title":"J Exp Med"},{"key":"7437_CR29","doi-asserted-by":"publisher","first-page":"100765","DOI":"10.1016\/j.genrep.2020.100765","volume":"20","author":"MJ Ramaiah","year":"2020","unstructured":"Ramaiah MJ. mTOR inhibition and p53 activation, microRNAs: the possible therapy against pandemic COVID-19. Gene Rep. 2020;20:100765.","journal-title":"Gene Rep"},{"issue":"1","key":"7437_CR30","first-page":"96","volume":"30","author":"SI Taha","year":"2022","unstructured":"Taha SI, Shata AK, El-Sehsah EM, Mohamed MF, Moustafa NM, Youssef MK. Comparison of COVID-19 characteristics in Egyptian patients according to their Toll-Like Receptor-4 (Asp299Gly) polymorphism. Infez Med. 2022;30(1):96\u2013103.","journal-title":"Infez Med"},{"key":"7437_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121393","volume":"283","author":"I Naqvi","year":"2022","unstructured":"Naqvi I, Giroux N, Olson L, Morrison SA, Llanga T, Akinade TO, Zhu Y, Zhong Y, Bose S, Arvai S, et al. DAMPs\/PAMPs induce monocytic TLR activation and tolerance in COVID-19 patients; nucleic acid binding scavengers can counteract such TLR agonists. Biomaterials. 2022;283: 121393.","journal-title":"Biomaterials"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07437-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07437-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07437-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T09:05:26Z","timestamp":1652173526000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07437-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,10]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7437"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07437-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,10]]},"assertion":[{"value":"9 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of Rafsanjan University of Medical Sciences (IR.RUMS.REC.1401.013) and all individuals voluntarily signed a written informed consent form. All methods were performed in accordance with the relevant guidelines and regulations by Rafsanjan University of Medical Sciences.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"448"}}